Skip to main content
Top

Clinical & Experimental Metastasis

Issue 1/2012

Content (8 Articles)

Research Paper

CD44 is a biomarker associated with human prostate cancer radiation sensitivity

WeiWei Xiao, Peter H. Graham, Carl A. Power, Jingli Hao, John H. Kearsley, Yong Li

Research Paper

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival

Alexandra Giatromanolaki, Efthimios Sivridis, Nikolaos E. Bechrakis, Gregor Willerding, Georgios St. Charitoudis, Michael H. Foerster, Kevin C. Gatter, Adrian L. Harris, Michael I. Koukourakis

Research Paper

Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma

Takanori Hama, Yuki Yuza, Toshihito Suda, Yoshimichi Saito, Chihiro Norizoe, Takakuni Kato, Hiroshi Moriyama, Mitsuyoshi Urashima

Research Paper

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

Niko Bretz, Aurelia Noske, Sascha Keller, Natalie Erbe-Hofmann, Thomas Schlange, Alexei V. Salnikov, Gerd Moldenhauer, Glen Kristiansen, Peter Altevogt

Research Paper

Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line

Szu-Tah Chen, Dah-Wel Liu, Jen-Der Lin, Fang-Wu Chen, Yu-Yao Huang, Brend Ray-Sea Hsu

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine